The emerging field of nanotube biotechnology

By C. Martin, P. Kohli. Nature reviews. Drug discovery, 2003

723 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Materials Chemistry

View Paper: https://www.semanticscholar.org/paper/c71726292a4e94d682b4f8a6ebe16907baec3ca5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. M. Prato
2. Kostas Kostarelos
3. A. Bianco
4. Chang Liu
5. C. Partidos
6. Hui‐Ming Cheng
7. P. Hou
8. Dusan Losic

In Materials Chemistry

1. Kostas Kostarelos
2. M. Prato
3. A. Bianco
4. C. Partidos
5. Chang Liu
6. Hui‐Ming Cheng
7. P. Hou
8. Dusan Losic

Citations in the corpus

• Metal Oxide Nanoparticles Induce Minimal Phenotypic Changes in a Model Colon Gut Microbiota (2015, neutral): “Nanotechnology offers many positive benefits to human health, such as more efficient drug delivery, sensor development for toxic substances detection, and medical diagnostic techniques (Thess et al., 1996; Kong et al., 2000; Long and Yang, 2001; Martin and Kohli, 2003); however, the increasing popul”
• Nanoporous anodic aluminium oxide: Advances in surface engineering and emerging applications (2013, methodology): “For example, exploiting the phenomenon of self-ordering during electrochemical anodization of metals has resulted in successful fabrication of highly ordered nanoporous metal oxide structures including anodic alumina oxide (AAO), nanotubular titania oxide (TNT) and porous silicon (pSi) [12–16].”
• Purification of carbon nanotubes (2008, background): “are considered to be excellent candidates for many potential applications, including but not limited to: catalyst and catalyst supports [3,4], composite materials [5,6], sensors and actuators [7,8], field emitters [9,10], tips for scanning probe microscopy [11,12], conductive films [13,14], bio-nano”
• Nanoparticle‐induced platelet aggregation and vascular thrombosis (2005, background): “Furthermore, with the ever growing use of engineered nanomaterials in targeted drug delivery, biosensor or imaging systems (Buxton et al., 2003; Martin & Kohli, 2003), the levels of nanoparticles in blood are bound to be increased.”
• Enzyme-responsive nanoparticles for drug release and diagnostics. (2012, background): “Amongmyriads of successful applications, healthcare can significantly benefit from the improved features of these nanomaterials [4, 5].”
• Surface and structural characterization of multi-walled carbon nanotubes following different oxidative treatments (2011, neutral): “[10] Martin CR, Kohli P.”
• Biomedical applications of functionalised carbon nanotubes. (2005, background): “Among the currently available delivery systems, which include liposomes, emulsions, polymers and microparticles (Lavan et al., 2003; Martin and Kohli, 2003; Allen and Cullis, 2004), carbon nanotubes (CNTs) have recently gained popularity as potential drug carriers, therapeutic agents and diagnostic ”